Summary
In 9 healthy subjects we evaluated the effect of a constant ranitidine infusion (100 mg) on glucose (mg/dl), insulin (µU/ml) and C-peptide (ng/ml) serum levels promoted by oral glucose tolerance test (75 g). Ranitidine significantly increased the area under concentration/time curves for glucose and insulin but not that of C-peptide. Our data indicate that ranitidine does not affect pancreatic insulin release nor peripheral glucose utilization and are consistent with the hypothesis that ranitidine influences the hepatic clearance of glucose and insulin both of which undergo high first-pass liver extraction.
Similar content being viewed by others
References
Barbara L., Corinaldesi R.: Endocrine effects of H2 receptor antagonist. Proc. Int. Symp. Exp. Clin. Evaluation Anti-ulcer Drugs, Pisa, November 22–23, 1982. S.K.F. Publ., Milano, 1982; p. 121.
Bogues K., Dixon G. T., Fowler P., Jenner W. M., Maconochie J. G., Martin L. E., Wiloughby B. A.: Pharmacokinetics and bioavailability of ranitidine in humans — Brit. J. Pharmacol.73, 275, 1981.
Bratusch-Marrain P. R., Waldhäusl W. K., Gasić S., Hofer A.: Hepatic disposal of biosynthetic human insulin and porcine C-peptide in humans — Metabolism33, 151, 1984.
Buchanan K. D., Spencer C. A., Ardil J., Kennedy T. L.: Altered release of gut and pancreatic hormones by H2-receptor antagonist in treatment of peptic ulcer — Scand. J. Gastroenterol.13, 34, 1978.
Clark A. J. L., Bilous R. W., Keen H.: Ranitidine in insulin-dependent diabetes — Lancetii, 883, 1982.
Delitala G., Devilla L., Pende A., Canessa A.: Effects of the H2-receptor antagonist ranitidine on anterior pituitary hormone secretion in man — Europ. J. clin. Pharmacol.22, 207, 1982.
Delitala G., Devilla L., Pende A., Lotti G.: Stimulation of prolactin induced by ranitidine, an antagonist of histamine H2-receptors in man — J. endocrinol. Invest.3, 12, 1980.
De Mattia G., Fini M., Laurenti I., Lalli S., Tullo M. G., Ventura C.: Effetti della ranitidina sul metabolismo glucidico — Policlinico, Sez. Prat.89, 644, 1982.
Feeley G., Guy E.: Ranitidine also reduces liver blood flow — Lanceti, 169, 1982.
Garg D. C., Weilder D. J., Jallad N. S., Eshelman F. N.: The effects of rantidine and cimetidine on hepatic blood flow — Clin. Pharmacol. Ther.31, 228, 1982.
Grahmen A., von Bahr C., Lindström B., Rosen A.: Bioavailability and pharmacokinetics of cimetidine — Europ. J. clin. Pharmacol.16, 335, 1979.
Grainger S. L., Marigold J. H., Keeling P. W. N.: Ranitidine and liver blood flow — Lanceti, 236, 1982.
Hittinger R., Knight S. E., Fielding L. P., Lawrence R.: The effect of cimetidine on blood sugar responses to glucose tolerance tests in human volunteers — Brit. J. Surg.65, 356, 1978.
Jefferys D. B., Vale G.A.: Effect of cimetidine on glucose handling — Lanceti, 383, 1978.
Katz A. I., Rubenstein A. H.: Metabolism of proinsulin, insulin and C-peptide in the rat — J. clin. Invest.52, 1113, 1973.
Marchesini G., Bianchi G., Zoli M., Dondi C., Forlani G., Melli A., Bua V., Vannini P., Pisi E.: Plasma amino acid response to protein ingestion in patients with liver cirrhosis — Gastroenterology85, 283, 1983.
McIsaac R. L., Knight S. E., Fielding L. T., Hittinger R.: Cimetidine and pancreatic function — Lanceti, 551, 1978.
Nelis G. F., van de Meene J. G. C.: Comparative effects of cimetidine and ranitidine on prolactin secretion — Postgrad. med. J.56, 478, 1980.
Netti C., Guidobono F., Olgiati V. R., Sibilia V., Pecile A.: Comparison of the effects of histamine H2 receptor antagonists on prolactin secretion. Proc. Int. Symp. Exper. Clin. Evaluation Anti-ulcer Drugs, Pisa, November 22–23, 1982. S.K.F. Publ., Milano, 1982; p. 87.
Ohnisashi K., Saito M., Nakayama T., Tsukamoto T., Sugita S., Terabayashi H., Wada K., Mishima A., Hatano H., Nomura F., Koen H., Okuda K.: Effect of intravenous load of ranitidine on hepatic hemodynamics — Jap. J. Gastroenterol.81, 1426, 1984.
Pomare E. W.: Hyperosmolar non-ketotic diabetes and cimetidine — Lanceti, 1202, 1978.
Scarpignano G., Tirelli F., Starcich R., Bertaccini G.: Insulin response to glucose loading after intravenous cimetidine — Drugs exp. clin. Res.7, 135, 1981.
Sibilia V., Netti C., Guidobono F., Olgiati V. R., Cazzamalli E., Pecile A.: Histamine H2 receptor antagonist and prolactin secretion. Proc. XXI Congr. Soc. Ital. di Farmacologia, Napoli, 2–5 giugno 1982. Idelson Publ., Napoli, 1982; p. 112.
Vernon R. G., Martino R., Unninghake D. B.: Cimetidine blockade of histamine — induced insulin secretion — Clin. Pharmacol. Ther.28, 392, 1980.
Williams R. L.: Drug administration in hepatic disease — New Engl. J. Med.309, 1616, 1983.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gentile, S., Marmo, R., Costume, A. et al. The role of ranitidine infusion on glucose, insulin and C-peptide serum levels induced by oral glucose tolerance test in healthy subjects. Acta diabet. lat 23, 165–170 (1986). https://doi.org/10.1007/BF02624676
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02624676